The Future of T-cell Depleted Haploidentical Stem Cell Transplantation

preview_player
Показать описание
Richard O’Reilly, MD, Memorial Sloan Kettering Cancer Center, presents on “Banked Third-Party Derived Virus-Specific T-Cells for Infections Following T-Cell Depleted Transplantation” at the 2024 International Symposium on αβ T-Cell/CD19 B-Cell Depleted Haploidentical Stem Cell Transplantation.
Рекомендации по теме